This HIV Post Exposure Prophylaxis (PEP) booklet aims to provide physicians with a comprehensive understanding of this critical intervention strategy. PEP refers to the administration of antiretroviral medications following potential exposure to the human immunodeficiency virus (HIV). Its primary goal is to prevent the establishment of HIV infection in individuals who have recently experienced a high-risk exposure incident. This booklet serves as a guide for healthcare providers, equipping them with the necessary knowledge to assess the eligibility of individuals for PEP, initiate timely treatment, and monitor patients throughout the course of therapy. By adhering to evidence-based guidelines, healthcare professionals can play a pivotal role in reducing the risk of HIV transmission and improving patient outcomes.

Philadelphia residents can get started on PEP within 72 hours of exposure by calling
the PEP hotline:
(833) 933-2815
or visit
phillykeeponloving.com/hiv-pep

What is PEP?

PEP, or Post Exposure Prophylaxis, involves the use of medication to prevent HIV transmission after a potential exposure.

Two Types:

  • Occupational PEP (oPEP) – Work exposure
  • Non-Occupational Post-Exposure Prophylaxis (nPEP) – non-work related

PEP Effectiveness

  • PEP is highly effective when taken within 72 hours of potential HIV exposure.

PEP is for Emergency Situations

  • It’s important to note that PEP should not be considered a substitute for regular use of other HIV prevention methods.
  • PEP is not intended for individuals who may be frequently exposed to HIV.
  • If an individual is at ongoing risk for HIV due to repeated exposures, it is advisable to consult a healthcare provider about PrEP (pre-exposure prophylaxis).

Types of Exposure

  • Post-exposure prophylaxis should be recommended, and immediate medical attention should be sought, when an individual reports a known or potential exposure to HIV within the past 72 hours.
  • Situations that warrant an immediate referral
    for PEP include:
    • Condomless receptive or insertive vaginal or anal intercourse with a partner living with HIV or a partner whose status was unknown, including intercourse that involved condom slippage or breakage
    • Needle-sharing
    • Injuries with exposure to blood or other potentially infected fluids from a source known to be HIV-infected or HIV status is unknown (including needlesticks with a hollow-bore needle, accidents, etc.)
  • For persons presenting with wounds or needlestick injuries
    • The site should be washed with soap and water, avoiding irritation of the skin.
    • The wound should not be “milked” or squeezed. Squeezing the wound may promote hyperemia and inflammation at the wound site, potentially increasing systemic exposure to HIV if present in the contaminating fluid.
  • Lower risk exposures that require evaluation by a clinical provider on a case-by-case basis include:
    • Oral-vaginal contact (receptive and insertive)
    • Oral-anal contact (receptive and insertive)
    • Receptive penile-oral contact with or without ejaculation
    • Insertive penile-oral contact with or without ejaculation
  • The level of risk in these situations increases with the presence of blood, genital ulcers, STD, or non-intact skin or mucus membrane.

According to CDC PEP guidelines, individuals who report an ongoing risk of HIV exposure (e.g., through injection drug use or condomless sex) or who have used more than one course of PEP in the past year should be provided with resources for HIV prevention, including an assessment for PrEP eligibility.

Prescribing PEP

This guide provides an evidence review, patient management guidelines, laboratory testing, recommended antiretroviral nPEP regimens, financial assistance for nPEP medication, and considerations for special populations. The table below describes preferred and alternative antiretroviral medication 28-day regimens for PEP.

Preferred and Alternative Antiretroviral Medication 28-day Regimens for nPEPa,b

Chart

Paying For PEP

  • Many insurance providers cover PEP.
  • If PEP is obtained through an emergency room, an individual may be given the first dose at the time of their visit, along with a few days’ supply. This will give them time to fill the prescription for the complete treatment course.
  • If an individual does not have insurance, their provider may be able to assist them with applying for medication assistance programs for PEP.
  • Enrollment applications that will be useful in applying for medication assistance programs are:
    • Gilead’s Advancing Access Form, at services.gileadhiv.com/content/pdf/gilead_enrollment_form.pdf, and
    • NASTAD’S Patient Assistance Tool, at nastad.org/resources/pharmaceutical-company-patient-assistance-programs-and-cost-sharing-assistance-programs

Additional Resources

Downloadable PDFs

  • Download the PEP book as a PDF

Resources and Links

Lorem ipsum dolor sit amet
Consectetur adipiscing elit
Ut elit tellus
Luctus nec ullamcorper mattis
Pulvinar dapibus leo.

FOR MORE HELP, CALL THE HEALTH INFORMATION HELPLINE AT 215-985-2437

Social Media Links:
Facebook
X (Twitter)

This site contains STI & HIV prevention messages that might not be appropriate for all audiences. Since these infections are spread primarily through sexual practices or by sharing needles, prevention messages may address these topics. If you are not seeking such information or may be offended by such materials, please leave this website.

This website is not intended as a substitute for your healthcare provider.